Skip to main content

Find Clinical Trials

Home
Conditions
Hepatitis C

Clinical trial condition

Hepatitis C

Explore clinical trials studying Hepatitis C. Study availability and eligibility vary by location and protocol.

449 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Hepatitis C trial results

Completed

A Study of Pharmacokinetics, Efficacy, Safety, Tolerability, of the Combination of Simeprevir (TMC435), Daclatasvir (BMS-790052), and Ribavirin (RBV) in Patients With Recurrent Chronic Hepatitis C Genotype 1b Infection After Orthotopic Liver Transplantation

NCT01938625

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Essen, Germany

Hamburg, Germany

Warsaw, Poland

Barcelona, Spain

View Trial Details

Completed

Efficacy and Safety of Oral Regimens for the Treatment of Chronic HCV Infection

NCT02202980

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Auckland, New Zealand

Christchurch, New Zealand

View Trial Details

Completed

Efficacy and Safety of Sofosbuvir Containing Regimens for the Treatment of Chronic HCV Infection in Participants With Chronic Genotype 1, 2, 3, or 6 HCV Infection

NCT01826981

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Auckland Clinical Studies Ltd. Auckland, New Zealand

Christchurch Clinical Studies Trust Christchurch, New Zealand

View Trial Details

Completed

Safety and Efficacy of LDV/SOF Fixed-Dose Combination (FDC) ± Ribavirin in HCV Genotype 1 Subjects

NCT01726517

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Virus, +15 more
Locations: San Antonio, Texas, United States

View Trial Details

Completed

Observational, Multi-Center Study of the Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in the Russian Federation

NCT02669940

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +16 more
Locations: Not specified

View Trial Details

Completed

Effects of Harvoni in Patients With Decompensated Cirrhosis Due to Hepatitis C Genotype 1 Infection

NCT02597166

Conditions: Blood-Borne Infections, Chronic Disease, Cirrhosis, Decompensated, +16 more
Locations: University Health Network - Toronto General Hospital Toronto, Ontario, Canada

View Trial Details

Completed

A Study Evaluating Slow Response/Non-Rapid Response in Patients With Chronic Hepatitis C, Genotype 1, 2, 3 & 4 Treated With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin)

NCT01429792

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Haemek Hospital; Gastroenterology Afula, Israel

Clalit City Ashdod MC; Liver Clinic Ashdod, Israel

Barzilai MC; Gastroenterology Ashkelon, Israel

Batyamon; Liver Unit Bat Yam, Israel

View all 26 locations

View Trial Details

Completed

Vaniprevir Administered With Pegylated-interferon and Ribavirin in Japanese Treatment-Naïve Chronic Hepatitis C Participants (MK-7009-043)

NCT01370642

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

Vaniprevir Plus PegIntron®/Ribavirin in Japanese Participants With Chronic Hepatitis C Who Are Non-responders to Previous Treatment (MK-7009-045)

NCT01405560

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

A Study to Investigate HCV Response Rates in Real World Patients: HEARTLAND Study

NCT03710252

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Not specified

View Trial Details